Working… Menu

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01424982
Recruitment Status : Recruiting
First Posted : August 29, 2011
Last Update Posted : May 17, 2021
Information provided by (Responsible Party):
M.D. Anderson Cancer Center